These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 17154501)

  • 1. 5-pyrrolidinylsulfonyl isatins as a potential tool for the molecular imaging of caspases in apoptosis.
    Kopka K; Faust A; Keul P; Wagner S; Breyholz HJ; Höltke C; Schober O; Schäfers M; Levkau B
    J Med Chem; 2006 Nov; 49(23):6704-15. PubMed ID: 17154501
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The nonpeptidyl caspase binding radioligand (S)-1-(4-(2-[18F]Fluoroethoxy)-benzyl)-5-[1-(2-methoxymethylpyrrolidinyl)sulfonyl]isatin ([18F]CbR) as potential positron emission tomography-compatible apoptosis imaging agent.
    Faust A; Wagner S; Law MP; Hermann S; Schnöckel U; Keul P; Schober O; Schäfers M; Levkau B; Kopka K
    Q J Nucl Med Mol Imaging; 2007 Mar; 51(1):67-73. PubMed ID: 17372575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fluorinated isatin derivatives. Part 2. New N-substituted 5-pyrrolidinylsulfonyl isatins as potential tools for molecular imaging of caspases in apoptosis.
    Podichetty AK; Wagner S; Schröer S; Faust A; Schäfers M; Schober O; Kopka K; Haufe G
    J Med Chem; 2009 Jun; 52(11):3484-95. PubMed ID: 19445513
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fluorinated isatin derivatives. Part 1: synthesis of new N-substituted (S)-5-[1-(2-methoxymethylpyrrolidinyl)sulfonyl]isatins as potent caspase-3 and -7 inhibitors.
    Podichetty AK; Faust A; Kopka K; Wagner S; Schober O; Schäfers M; Haufe G
    Bioorg Med Chem; 2009 Apr; 17(7):2680-8. PubMed ID: 19299147
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of 4- or 5-substituents on the pyrrolidine ring of 5-[1-(2-methoxymethylpyrrolidinyl)sulfonyl]isatin derivatives on their inhibitory activities towards caspases-3 and -7.
    Limpachayaporn P; Riemann B; Kopka K; Schober O; Schäfers M; Haufe G
    Eur J Med Chem; 2013 Jun; 64():562-78. PubMed ID: 23685941
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis of new fluorinated, 2-substituted 5-pyrrolidinylsulfonyl isatin derivatives as caspase-3 and caspase-7 inhibitors: nonradioactive counterparts of putative PET-compatible apoptosis imaging agents.
    Limpachayaporn P; Schäfers M; Schober O; Kopka K; Haufe G
    Bioorg Med Chem; 2013 Apr; 21(7):2025-36. PubMed ID: 23411396
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fluorinated isatin derivatives. Part 3. New side-chain fluoro-functionalized pyrrolidinyl sulfonyl isatins as potent caspase-3 and -7 inhibitors.
    Podichetty AK; Wagner S; Faust A; Schäfers M; Schober O; Kopka K; Haufe G
    Future Med Chem; 2009 Aug; 1(5):969-89. PubMed ID: 21426092
    [TBL] [Abstract][Full Text] [Related]  

  • 8. N-benzylisatin sulfonamide analogues as potent caspase-3 inhibitors: synthesis, in vitro activity, and molecular modeling studies.
    Chu W; Zhang J; Zeng C; Rothfuss J; Tu Z; Chu Y; Reichert DE; Welch MJ; Mach RH
    J Med Chem; 2005 Dec; 48(24):7637-47. PubMed ID: 16302804
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isatin sulfonamide analogs containing a Michael addition acceptor: a new class of caspase 3/7 inhibitors.
    Chu W; Rothfuss J; d'Avignon A; Zeng C; Zhou D; Hotchkiss RS; Mach RH
    J Med Chem; 2007 Jul; 50(15):3751-5. PubMed ID: 17585855
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis of 7-halogenated isatin sulfonamides: nonradioactive counterparts of caspase-3/-7 inhibitor-based potential radiopharmaceuticals for molecular imaging of apoptosis.
    Limpachayaporn P; Wagner S; Kopka K; Schober O; Schäfers M; Haufe G
    J Med Chem; 2014 Nov; 57(22):9383-95. PubMed ID: 25358116
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis, radiolabeling, and in vivo evaluation of an 18F-labeled isatin analog for imaging caspase-3 activation in apoptosis.
    Zhou D; Chu W; Rothfuss J; Zeng C; Xu J; Jones L; Welch MJ; Mach RH
    Bioorg Med Chem Lett; 2006 Oct; 16(19):5041-6. PubMed ID: 16891117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro cytotoxicity evaluation of some substituted isatin derivatives.
    Vine KL; Locke JM; Ranson M; Benkendorff K; Pyne SG; Bremner JB
    Bioorg Med Chem; 2007 Jan; 15(2):931-8. PubMed ID: 17088067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis, 18F-radiolabeling, and in vivo biodistribution studies of N-fluorohydroxybutyl isatin sulfonamides using positron emission tomography.
    Limpachayaporn P; Wagner S; Kopka K; Hermann S; Schäfers M; Haufe G
    J Med Chem; 2013 Jun; 56(11):4509-20. PubMed ID: 23656488
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An investigation into the cytotoxicity and mode of action of some novel N-alkyl-substituted isatins.
    Vine KL; Locke JM; Ranson M; Pyne SG; Bremner JB
    J Med Chem; 2007 Oct; 50(21):5109-17. PubMed ID: 17887662
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and in vitro evaluation of sulfonamide isatin Michael acceptors as small molecule inhibitors of caspase-6.
    Chu W; Rothfuss J; Chu Y; Zhou D; Mach RH
    J Med Chem; 2009 Apr; 52(8):2188-91. PubMed ID: 19326941
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel fluorine-18 labeled 5-(1-pyrrolidinylsulfonyl)-7-azaisatin derivatives as potential PET tracers for in vivo imaging of activated caspases in apoptosis.
    Waldmann CM; Hermann S; Faust A; Riemann B; Schober O; Schäfers M; Haufe G; Kopka K
    Bioorg Med Chem; 2015 Sep; 23(17):5734-9. PubMed ID: 26210158
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biochemical and biophysical characterization of inhibitor binding to caspase-3 reveals induced asymmetry.
    Aulabaugh A; Kapoor B; Huang X; Dollings P; Hum WT; Banker A; Wood A; Ellestad G
    Biochemistry; 2007 Aug; 46(33):9462-71. PubMed ID: 17649976
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective inhibition of carboxylesterases by isatins, indole-2,3-diones.
    Hyatt JL; Moak T; Hatfield MJ; Tsurkan L; Edwards CC; Wierdl M; Danks MK; Wadkins RM; Potter PM
    J Med Chem; 2007 Apr; 50(8):1876-85. PubMed ID: 17378546
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel nonpeptidic caspase-3/7 inhibitor, (S)-(+)-5-[1-(2-methoxymethylpyrrolidinyl)sulfonyl]isatin reduces myocardial ischemic injury.
    Chapman JG; Magee WP; Stukenbrok HA; Beckius GE; Milici AJ; Tracey WR
    Eur J Pharmacol; 2002 Dec; 456(1-3):59-68. PubMed ID: 12450570
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design, synthesis, and evaluation of aza-peptide Michael acceptors as selective and potent inhibitors of caspases-2, -3, -6, -7, -8, -9, and -10.
    Ekici OD; Li ZZ; Campbell AJ; James KE; Asgian JL; Mikolajczyk J; Salvesen GS; Ganesan R; Jelakovic S; Grütter MG; Powers JC
    J Med Chem; 2006 Sep; 49(19):5728-49. PubMed ID: 16970398
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.